|
|
Line 73: |
Line 73: |
|
| |
|
| ===Staging=== | | ===Staging=== |
| There is a system by Masaoka and colleagues<ref name=pmid7296496 >{{Cite journal | last1 = Masaoka | first1 = A. | last2 = Monden | first2 = Y. | last3 = Nakahara | first3 = K. | last4 = Tanioka | first4 = T. | title = Follow-up study of thymomas with special reference to their clinical stages. | journal = Cancer | volume = 48 | issue = 11 | pages = 2485-92 | month = Dec | year = 1981 | doi = | PMID = 7296496 }}</ref> that was subsequently modified, and is known as the ''modified Masaoka staging system''.<ref name=pmid8044305>{{Cite journal | last1 = Koga | first1 = K. | last2 = Matsuno | first2 = Y. | last3 = Noguchi | first3 = M. | last4 = Mukai | first4 = K. | last5 = Asamura | first5 = H. | last6 = Goya | first6 = T. | last7 = Shimosato | first7 = Y. | title = A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. | journal = Pathol Int | volume = 44 | issue = 5 | pages = 359-67 | month = May | year = 1994 | doi = | PMID = 8044305 }}</ref>
| | {{Main|Thymic staging}} |
| | |
| ====Based on CAP protocol====
| |
| Staging as per Butnor ''et al.'':<ref>Butnor KJ et al. Thymus. Version 3.1.0.0. 2011. URL: [http://www.cap.org/cancerprotocols www.cap.org/cancerprotocols]. Accessed on: 31 August 2015.</ref>
| |
| {| class="wikitable sortable"
| |
| !Stage
| |
| !Characteristics
| |
| |-
| |
| |I
| |
| |encapsulated lesion, tumour does not penetrate capsule
| |
| |-
| |
| |IIa
| |
| |microscopic penetration of the capsule
| |
| |-
| |
| |IIb
| |
| |macroscopic penetration of the capsule
| |
| |-
| |
| |III
| |
| |macroscopic invasion of adjacent organs
| |
| |-
| |
| |IVa
| |
| |pleural or pericardial spread
| |
| |-
| |
| |IVb
| |
| |lymphatic or hematogenous spread
| |
| |}
| |
| | |
| ====Modified Masaoka as per Masaoka ''et al.'' (1999)====
| |
| T-stage - based on Masaoka ''et al.'' (1999):<ref name=pmid10047676>{{Cite journal | last1 = Masaoka | first1 = A. | last2 = Yamakawa | first2 = Y. | last3 = Fujii | first3 = Y. | title = Well-differentiated thymic carcinoma: is it thymic carcinoma or not? | journal = J Thorac Cardiovasc Surg | volume = 117 | issue = 3 | pages = 628-30 | month = Mar | year = 1999 | doi = | PMID = 10047676 }}</ref>
| |
| {| class="wikitable sortable"
| |
| !Stage
| |
| !Features
| |
| |-
| |
| | T1
| |
| | macroscopically and microscopically encapulated
| |
| |-
| |
| | T2
| |
| | macroscopic invasion or adhesion to surrounding tissue (fat or pleura) ''or'' microscopic invasion into the capsule
| |
| |-
| |
| | T3
| |
| | Spread to adjacent organs, e.g. pericardium, lung, great vessels.
| |
| |-
| |
| | T4
| |
| | pericardial or pleural spread
| |
| |}
| |
| | |
| N-stage - based on Masaoka ''et al.'' (1999):<ref name=pmid10047676>{{Cite journal | last1 = Masaoka | first1 = A. | last2 = Yamakawa | first2 = Y. | last3 = Fujii | first3 = Y. | title = Well-differentiated thymic carcinoma: is it thymic carcinoma or not? | journal = J Thorac Cardiovasc Surg | volume = 117 | issue = 3 | pages = 628-30 | month = Mar | year = 1999 | doi = | PMID = 10047676 }}</ref>
| |
| {| class="wikitable sortable"
| |
| !Stage
| |
| !Features
| |
| |-
| |
| | N0
| |
| | no lymph node spread
| |
| |-
| |
| | N1
| |
| | spread to anterior mediastinal lymph nodes
| |
| |-
| |
| | N2
| |
| | spread to intrathoracic lymph nodes other than the mediastinal lymph nodes
| |
| |-
| |
| | N3
| |
| | spread to supraclavicular lymph nodes
| |
| |}
| |
| | |
| M-stage - based on Masaoka ''et al.'' (1999):<ref name=pmid10047676>{{Cite journal | last1 = Masaoka | first1 = A. | last2 = Yamakawa | first2 = Y. | last3 = Fujii | first3 = Y. | title = Well-differentiated thymic carcinoma: is it thymic carcinoma or not? | journal = J Thorac Cardiovasc Surg | volume = 117 | issue = 3 | pages = 628-30 | month = Mar | year = 1999 | doi = | PMID = 10047676 }}</ref>
| |
| {| class="wikitable sortable"
| |
| !Stage
| |
| !Features
| |
| |-
| |
| | M0
| |
| | no hematogeneous spread and extrathoracic lymph nodes with the exception of the supraclavicular nodes
| |
| |-
| |
| | M1
| |
| | hematogeneous spread and/or extrathoracic lymph nodes
| |
| |}
| |
|
| |
|
| ==IHC== | | ==IHC== |